ACL 1.32% $2.25 australian clinical labs limited

News: ACL Australia's ACCC Consults On ACL's Proposed Divestiture For Healius Deal

  1. 188,784 Posts.
    lightbulb Created with Sketch. 2765

    Oct 3 (Reuters) - Australian Clinical Labs Ltd (ACL) :

    • ACCC CONSULTS ON ACL'S PROPOSED DIVESTITURE REMEDY FOR HEALIUS ACQUISITION
    • SEEKING VIEWS ON PROPOSED COURT-ENFORCEABLE UNDERTAKING OFFERED BY ACL IN RELATION TO PROPOSED ACQUISITION OF HEALIUS LIMITED
    • PROPOSED UNDERTAKING WOULD REQUIRE ACL TO DIVEST 60 ACCS IN PERTH, 25 ACCS ACROSS REGIONAL VICTORIA, AND 14 ACCS IN THE NORTHERN TERRITORY
    • DIVESTED ASSETS REPRESENT 16% OF COMBINED APPROVED COLLECTION CENTRES NETWORK OF ACL AND HEALIUS IN WESTERN AUSTRALIA AND 2% IN VICTORIA

    (([email protected];))

 
watchlist Created with Sketch. Add ACL (ASX) to my watchlist
(20min delay)
Last
$2.25
Change
-0.030(1.32%)
Mkt cap ! $454.1M
Open High Low Value Volume
$2.28 $2.28 $2.19 $1.902M 853.1K

Buyers (Bids)

No. Vol. Price($)
1 4672 $2.23
 

Sellers (Offers)

Price($) Vol. No.
$2.27 3500 1
View Market Depth
Last trade - 16.10pm 05/06/2024 (20 minute delay) ?
Last
$2.26
  Change
-0.030 ( 0.78 %)
Open High Low Volume
$2.28 $2.28 $2.20 141881
Last updated 15.59pm 05/06/2024 ?
ACL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.